Avecho Biotechnology Ltd (AVE) — Cash Flow Reinvestment Rate
Avecho Biotechnology Ltd (AVE) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$2.27 Million. Explore AVE capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Avecho Biotechnology Ltd Cash Flow Reinvestment Rate (1993–2025)
Historical reinvestment intensity for Avecho Biotechnology Ltd across 3 annual periods. Also explore how large is Avecho Biotechnology Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Avecho Biotechnology Ltd (1993–2025)
Year-by-year capital reinvestment analysis for Avecho Biotechnology Ltd. For live market cap and broader valuation context, see AVE company net worth.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | AU$0.00 | AU$1.10 Million | AU$0.00 | ▼ -100.0% |
| 2019 | 0.01x | AU$16.21K | AU$1.19 Million | AU$5.15K | — |
| 1993 | 0.00x | AU$0.00 | AU$23.00K | AU$0.00 | — |